RYR2 and catecholaminergic polymorphic ventricular tachycardia: Two groups first identified RyR2 mutations in CPVT patients; neither reported structural cardiac abnormalities or echocardiographic evidence of cardiac failure (Laitinen et al. 2001, Priori et al. 2001).